Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipopolysaccharide lipid A is the highly conserved, hydrophobic anchor of lipopolysaccharide (LPS) located in the outer leaflet of the outer membrane of Gram-negative bacteria. Often referred to as endotoxin, it is the primary bioactive component responsible for the potent inflammatory response associated with Gram-negative infections (Raetz & Whitfield, 2002, Annu Rev Biochem). Lipid A is recognized by the human innate immune system through the Toll-like receptor 4 (TLR4) and myeloid differentiation factor 2 (MD-2) complex, which triggers the release of pro-inflammatory cytokines (Park et al., 2009, Nature). While essential for bacterial viability and membrane stability, Lipid A serves as a critical therapeutic target for cationic antimicrobial peptides like polymyxins, which bind to its phosphate groups to disrupt the bacterial cell wall (Poirel et al., 2017, Clin Microbiol Rev). Furthermore, Lipid A is a focal point in the development of anti-sepsis therapies aimed at neutralizing its activity or blocking its interaction with host receptors to prevent septic shock (Hotchkiss et al., 2016, Nat Rev Dis Primers). Its synthesis and transport from the cytoplasmic membrane to the outer membrane are also targets for novel antibiotic development.
Binding to the lipid A moiety of lipopolysaccharide to disrupt the bacterial outer membrane; competitive antagonism of the TLR4/MD-2 receptor complex to prevent endotoxin-induced cytokine release.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide lipid A (Lipid A).